<?xml version="1.0"?> 
<rss version="2.0">

	<channel>
		<title>Chembio Diagnostics, Inc. (CEMI) research, news, and more from GeoInvesting</title>
		<description>The latest research, news, and more from GeoInvesting for Chembio Diagnostics, Inc. (CEMI)</description>
		<link>/companies/cemi_chembio_diagnostics__inc_/overview</link>
		<language>en-us</language>
		<pubDate>Fri, 17 Apr 2026 05:41:41 GMT</pubDate>
		<lastBuildDate>Fri, 17 Apr 2026 05:41:41 GMT</lastBuildDate>
        <ttl>120</ttl>
        
        <item><title>Hot Bio-Tech News</title><guid isPermaLink="false">37779</guid><pubDate>Fri, 21 Dec 2012 05:00:00 GMT</pubDate><description>Receives FDA Approval for DPP(R) Point-of-Care HIV 1/2 Rapid Test (&lt;A  href=&quot;www.prnewswire.com/news-releases/fda-grants-soligenix-orphan-drug-designation-for-orbeshield-for-treatment-after-exposure-to-a-radiological-disaster-185404662.html&quot; target=_blank&gt;source&lt;/A&gt;)</description><link>/companies/cemi_chembio_diagnostics__inc_/research&amp;item=37779</link></item>
            
	
	</channel>  
	
</rss>
